Prestige Consumer Healthcare Inc. PBH
52.60 USD +3.05 (+6.17%)
Nov 4, 2026, 12:38 PM EST
50.72 Day range 52.99
42.62 52-week range 71.07
- YTD
- -14.74%
- 1 year
- -13.11%
Analyst view
Consensus: buy
Buy
Price target (mean) 67.80 +28.9% upside
Now 52.60
- Target (low)
- 55.00
- Target (mean)
- 67.80
- Target (high)
- 75.00
Ratings (0m) 7 5 buy · 2 hold · 0 sell
- Strong buy0
- Buy5
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
- 3 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.07 | 1.06 – 1.08 | 0.86 | +24.8% | 329.12M | +20.1% | 7 |
| Next quarter | 1.23 | 1.20 – 1.26 | 1.14 | +8.1% | 351.75M | +24.1% | 7 |
| Current year | 4.58 | 4.55 – 4.63 | 4.38 | +4.7% | 1.30B | +19.2% | 8 |
| Next year | 5.11 | 4.90 – 5.34 | 4.58 | +11.5% | 1.38B | +6.3% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 15, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 14, 2026 | Oppenheimer | Downgrade | Outperform | Perform |
| May 7, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Feb 2, 2026 | Jefferies | Maintained | Hold | Hold |
| Nov 7, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 27, 2025 | Jefferies | Maintained | Hold | Hold |
| Oct 21, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 8, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 21, 2025 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Feb 13, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Feb 7, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Feb 7, 2025 | DA Davidson | Maintained | Buy | Buy |
| Nov 11, 2024 | DA Davidson | Maintained | Buy | Buy |
| Aug 28, 2024 | DA Davidson | Maintained | Buy | Buy |
| Aug 9, 2024 | DA Davidson | Maintained | Buy | Buy |
| Aug 9, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Jun 21, 2024 | DA Davidson | Upgrade | Neutral | Buy |
| May 21, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| May 16, 2024 | DA Davidson | Maintained | Neutral | Neutral |
| Jun 26, 2023 | DA Davidson | Reiterated | Neutral | Neutral |
| May 8, 2023 | DA Davidson | Reiterated | — | Neutral |
| Mar 17, 2023 | RBC Capital | Maintained | — | Sector Perform |
| Feb 17, 2023 | Oppenheimer | Maintained | — | Outperform |
| Jan 13, 2023 | Oppenheimer | Maintained | — | Outperform |
| Nov 17, 2022 | Canaccord Genuity | Initiated | — | Buy |
| May 10, 2022 | Jefferies | Upgrade | Hold | Buy |
| May 9, 2022 | Oppenheimer | Upgrade | Perform | Outperform |
| May 9, 2022 | DA Davidson | Maintained | — | Neutral |
| Nov 15, 2021 | DA Davidson | Maintained | — | Neutral |
| Aug 6, 2021 | DA Davidson | Maintained | — | Neutral |
